Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion type Assertion NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_head.
- NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion description "[MLL (ALL1, Htrx, HRX), which is located on chromosome band 11q23, frequently is rearranged in patients with therapy-related acute myeloid leukemia who previously were treated with DNA topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_provenance.
- NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion evidence source_evidence_literature NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_provenance.
- NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion SIO_000772 10339604 NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_provenance.
- NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion wasDerivedFrom befree-20150227 NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_provenance.
- NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_assertion wasGeneratedBy ECO_0000203 NP787112.RAsk_dt22cLOU0HZeWK16Pv7JCrMckOMLYSuaioNgc_J0130_provenance.